Beximco Pharmaceuticals Limited Total Liabilities

The latest total liabilities for BXP.L is $14B as of March 2026. That compares with $19B in the prior-year period — down 24.9% year over year. Investors often review this figure alongside Beximco Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, BXP.L's total liabilities moved from $19B to $14B — a 24.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Beximco Pharmaceuticals Limited's operating scale or balance-sheet position.

A total liabilities figure of $14B for BXP.L is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BXP.L's total liabilities ($14B), review year-over-year change from $19B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.